( in Million)
Particulars
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Audited / UnAudited
UnAudited
Audited
Audited
Audited
Net Sales
1054470
701080
723490
1044070
Total Expenditure
941880
692290
737530
941830
PBIDT (Excl OI)
112590
8790
-14040
102240
Other Income
16330
14670
14610
15190
Operating Profit
128920
23460
570
117430
Exceptional Items
1100
-15970
-26080
-560
PBDT
122350
670
-32370
107490
Depreciation
50920
49690
48710
53200
Profit Before Tax
71430
-49020
-81080
54290
Tax
13990
-12500
-17020
15580
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
57440
-36520
-64060
38710
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
57440
-36520
762100
38710
Minority Interest
-950
-30
-780
-790
Shares of Associates
1340
1690
380
1320
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
57830
-34860
761700
39240
Equity Capital
7370
7370
7370
7360
Calculated EPS
15.69
-9.45
206.70
10.66
Calculated EPS (Annualised)
62.77
-37.83
826.81
42.65
No of Public Share Holdings
2115008566
2114961561
2114904841
2114092513
% of Public Share Holdings
57.44
57.44
57.43
57.43
PBIDTM% (Excl OI)
10.67
1.25
-1.94
9.79
PBIDTM%
12.22
3.34
0.07
11.24
PBDTM%
11.60
0.09
-4.47
10.29